Quel est le prix pour Anteris Technologies Global Corp. (AVR)

Le prix pour Anteris Technologies Global Corp. (AVR) est $8.88

Quelle est la capitalisation boursière pour Anteris Technologies Global Corp. (AVR)

La capitalisation boursière pour Anteris Technologies Global Corp. (AVR) est $863.29M

Anteris Technologies Global Corp. (AVR) Marge Opérationnelle

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Année	Marge opérationnelle	Changez
Pas assez de données pour les dates fournies.

Année

Marge opérationnelle

Changez

Pas assez de données pour les dates fournies.

Entreprise	Marge opérationnelle	Différence de Marge Opérationnelle	Pays
Abbott Laboratories ABT.US	17.03%	-	US
Stryker Corporation SYK.US	22.03%	-	US
Medtronic plc MDT.US	17.86%	-	IE
Boston Scientific Corporation BSX.US	21.46%	-	US
Siemens Healthineers AG SHL.DE	0.00%	-	DE

Entreprise

Marge opérationnelle

Différence de Marge Opérationnelle

Pays